Synutra International (SYUT) shares advanced in extended trading after the Chinese baby-formula maker reported fiscal Q4 profit more than tripled and provided full-year revenue guidance above Wall Street’s estimates.
Shares of the Rockville, Maryland-based company was up 3.7% at $6.60 after closing up 3.1% at $6.36 on Monday.
Net income increased to $10.1 million, or $0.18 per diluted share, in the three months ended March 31, from $3.3 million, or $0.06 per diluted share, in the year-ago period.
Q4 sales rose to $98.7 million from $72.9 million year-over-year.
Looking ahead, the Company expects strong top line growth and greater operating leverage in fiscal 2015, with full year revenue growth expected to be at least 20% over fiscal 2014 results, or between $450 to $500 million.
One analyst projects annual revenue of $420 million, according to Capital IQ data.
The stock has lost 28% so far this year.